Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.41 -0.05%   SPY: 165.31 -0.09%
Quote Spy PATH NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


NuPathe (PATH)

@ May-24
Click the portfolio to add PATH:
Close [X]
+ Add PATH to Portfolio
  
  Last Trade: $3.17 +0.06 (1.93%)
  Volume: 93,450 61% of avg daily volume
       
  Avg Volume: 153,036
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 3.06 - 3.24
  Open: 3.12
  Previous Close: 3.11
  52-wk Range: 2.47 - 4.59
  Market Cap: 92.1M
  P/E: -1.1
  Div Yield: $0.00 (0.00%)
Indexes
2010 IPOs (-0.2%)
Pain Management Stoc... (+0.6%)
Spy PATH

? Pro holders
? Member holders
? Items submitted
Additional PATH resources



Customize Links
To see which Pros and tickerspy members own PATH Sign up now
Latest PATH Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

NuPathe Announces First Quarter 2013 Financial Results and Operational Highlights
PATH  
Linked by marketwire - May 14, 07:30AM from (www2.marketwire.com)
NuPathe Inc. (NASDAQ: PATH) today announced financial results for the quarter ended March 31, 2013, as well as recent operational  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NuPathe to Host Conference Call to Discuss First Quarter 2013 Results on Tuesday, May 14, 2013
PATH  
Linked by marketwire - May 07, 08:30AM from (www2.marketwire.com)
NuPathe Inc. (NASDAQ: PATH) will host a conference call on Tuesday, May 14, 2013, at 8:30 a.m. EDT to discuss first quarter  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NuPathe Announces Fourth Quarter and Full Year 2012 Financial Results and Operational Highlights
PATH  
Linked by marketwire - March 26, 07:44AM from (www2.marketwire.com)
NuPathe Inc. (NASDAQ: PATH) today announced financial results for the quarter and full year ended December 31, 2012, as well  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NuPathe to Host Conference Call to Discuss Fourth Quarter and Full Year 2012 Results on Tuesday, March 26, 2013
PATH  
Linked by marketwire - March 19, 08:44AM from (www2.marketwire.com)
NuPathe Inc. (NASDAQ: PATH) will host a conference call on Tuesday, March 26, 2013, at 8:30 a.m. EDT to discuss fourth quarter  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NuPathe Wins U.S. FDA Approval for Migraine Skin Patch
PATH  
Linked by Bloomberg - January 17, 06:40PM from (www.bloomberg.com)
NuPathe Inc. (PATH), a maker of neurological and psychiatric medicines, won U.S. regulatory approval for the first skin patch to treat migraines.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NuPathe Announces Third Quarter 2012 Financial Results and Operational Highlights
SFE  AUXL  PATH  
Linked by marketwire - November 12, 07:30AM from (www2.marketwire.com)
NuPathe Inc. (NASDAQ: PATH), a specialty pharmaceutical company focused on the development and commercialization of branded  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NuPathe to Host Conference Call to Discuss Third Quarter 2012 Results on Monday, November 12, 2012
PATH  
Linked by marketwire - November 05, 05:00PM from (www2.marketwire.com)
NuPathe Inc. (NASDAQ: PATH), a specialty pharmaceutical company focused on the development and commercialization of branded  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NuPathe Announces Second Quarter 2012 Financial Results and Operational Highlights
AUXL  PATH  
Linked by marketwire - August 14, 07:30AM from (www2.marketwire.com)
NuPathe Inc. (NASDAQ: PATH), a specialty pharmaceutical company focused on the development and commercialization of branded  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NuPathe to Report Second Quarter 2012 Results and Hold Conference Call on Tuesday, August 14, 2012
PATH  
Linked by marketwire - August 09, 04:15PM from (www2.marketwire.com)
NuPathe Inc. (NASDAQ: PATH), a specialty pharmaceutical company focused on the development and commercialization of branded  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NuPathe Appoints Armando Anido as Chief Executive Officer
AUXL  PATH  
Linked by marketwire - July 25, 07:30AM from (www2.marketwire.com)
NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on the development and commercialization of branded therapeutics  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource